Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 6, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc..
Metrics to compare | RENJ | Peers Peers - average of corresponding metrics from companies closely matching RENJ: | Sector Sector - Average of metrics from a broad group of related Energy sector companies | Relationship RelationshipRENJPeersSector |
|---|---|---|---|---|
P/E Ratio | −4.7x | 0.0x | 6.0x | |
PEG Ratio | 0.04 | 0.00 | 0.00 | |
Price/Book | 1.6x | 0.0x | 1.1x | |
Price / LTM Sales | 25.7x | 0.0x | 1.3x | |
Upside (Analyst Target) | - | 0.0% | 14.2% | |
Fair Value Upside | Unlock | 0.0% | 7.0% | Unlock |